
Lung Cancer Europe
@LungCancerEu
Followers
2K
Following
10K
Media
1K
Statuses
4K
LuCE is the voice of people affected by lung cancer in Europe, advocating and networking to improve outcomes for the community. #LungCancer #LCSM
Europe
Joined December 2016
RT @LungCancerEu: Could POCUS-guided lung biopsies speed up diagnosis & improve pathways?. A Canadian team tested using handheld ultrasoundโฆ.
0
2
0
RT @NEJM: Original Article: Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer (CheckMate 816 phase 3 trial) httpโฆ.
0
32
0
RT @DrDominicNg: A massive genetic study in @Nature just identified why chronic pain hits some people harder than others. They discoveredโฆ.
0
165
0
RT @ConorMoloneyOnc: Thrilled to see my review on immunotherapy in resectable NSCLC ๐ซ now published in @TAMedOncol! Huge thanks to @FordePaโฆ.
journals.sagepub.com
Non-small-cell lung cancer (NSCLC) accounts for 80%โ85% of all lung cancer cases, being the leading cause of cancer-related mortality worldwide. Historically, o...
0
3
0
RT @NEJM: ๐๐ฌ๐ ๐จ๐ ๐ญ๐ก๐ ๐๐๐
๐-๐๐ (๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ, ๐๐ฏ๐ข๐๐๐ง๐๐, ๐
๐๐๐๐๐๐๐ค, ๐๐ง๐ ๐๐๐๐๐ก๐ข๐ง๐ ) ๐
๐ซ๐๐ฆ๐๐ฐ๐จ๐ซ๐ค ๐ญ๐จ ๐๐ซ๐จ๐ฆ๐จ๐ญ๐ ๐๐ซ๐ข๐ญ๐ข๐๐๐ฅ ๐๐ก๐ข๐ง๐ค๐ข๐ง๐ ๐๐ฎ๐ซ๐ข๐ง๐ ๐๐ง ๐๐ ๐๐ง๐ญ๐๐ซ๐๐๐ญ๐ข๐จ๐งโฆ.
0
83
0
RT @ASCO: ๐ @montypal of @cityofhope and Dr. Arielle Elkrief of @chumontreal @CRCHUM discuss the emerging phenomenon of the gut microbiomeโฆ.
0
11
0
RT @dplanchard: With targeted therapies and immunotherapy, the progress in treating early-stage NSCLC over the past few years has been imprโฆ.
0
17
0
RT @chadinabhan: The โCHALLENGEโ trial presented at โฆ@ASCOโฉ #ASCO25 & pub in โฆ@NEJMโฉ made a lot of noise - exercise improves OS?.The PI himโฆ.
0
3
0
RT @KatsuakiMaehara: Deep Learning Model for Predicting Immunotherapy Response in Advanced NonโSmall Cell Lung Cancer | Artificial Intelligโฆ.
jamanetwork.com
This multicenter cohort study develops and assesses the validity of a deep learning model for predicting immune checkpoint inhibitor response in patients with advanced nonโsmall cell lung cancer.
0
2
0
RT @ADesaiMD: Out in @JTOonline research shows that immunohistochemistry (IHC) is a more reliable method to detect MTAP deficiency in non-sโฆ.
0
16
0
Could POCUS-guided lung biopsies speed up diagnosis & improve pathways?. A Canadian team tested using handheld ultrasound (POCUS) to guide lung biopsies in clinic, avoiding long waits for CT scans & radiology slots. POCUS isnโt new, but using it this way for #lungcancer
0
2
7
RT @eurordis: How can patient-clinician partnership improve rare disease communication?. Discover Lupus100โa co-created, multilingual infoโฆ.
0
6
0
โ๏ธAlmost 1/2 of those with #lungcancer donโt feel heard in decisions about their care. Next month at #WCLC25 weโll present โKnowledge & Shared Decision Making - a European Experienceโ. Weโll be addressing gaps in knowledge, access to information & involvement in decision-making
0
8
19
RT @Cracking_Cancer: Found a nodule on a scan? The vast majority are not cancerous. Dr. Concannon explains that nodules are often just yourโฆ.
0
5
0
RT @diegoadiazg: ๐ฆ Gut microbiota influences response, resistance, and toxicity to ICIs. Antibiotic use before/during therapy worsens surโฆ.
0
3
0
RT @diegoadiazg: ๐งฌ LIQUIK study. In metastatic #NSCLC, LiquidHALLMARK (ctDNA+ctRNA) improved biomarker detection vs ctDNA alone:.๐น +28.6%โฆ.
0
15
0
RT @LungCancerEu: New evidence confirms vaping is a gateway with broad risks for young people:. โช๏ธ Vaping consistently linked to later cigaโฆ.
0
2
0
RT @UOzkerim: Game-changer in resectable NSCLC:.Neoadjuvant nivolumab + chemo โ 5-yr OS 65% vs 55%. Patients achieving pCR: OS โ 95% ๐ฅ.Theโฆ.
0
6
0
RT @DrewMoghanaki: How high-precision radiation therapy helped a surfer beat lung cancer and get back in the water | UCLA Health https://t.โฆ.
uclahealth.org
When Paul Hendrix was diagnosed with early-stage lung cancer in 2023, he knew exactly where to turn. A longtime UCLA Health patient and alumnus of UCLAโs film and television program, Hendrix had...
0
5
0
RT @Cracking_Cancer: What is cancer? It's when cells lose their ability to stop dividing and start to grow uncontrollably. When we say "lunโฆ.
0
2
0